Innoviva, Inc.
INVA
$20.92
$0.040.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 128.97M | 128.72M | 116.98M | 107.37M | 88.62M |
| Total Other Revenue | 241.26M | 241.13M | 241.73M | 245.38M | 241.88M |
| Total Revenue | 370.23M | 369.84M | 358.71M | 352.75M | 330.50M |
| Cost of Revenue | 60.48M | 52.94M | 47.96M | 67.13M | 67.36M |
| Gross Profit | 309.75M | 316.90M | 310.76M | 285.61M | 263.13M |
| SG&A Expenses | 111.45M | 112.78M | 115.69M | 110.68M | 113.10M |
| Depreciation & Amortization | 26.04M | 25.94M | 25.90M | 25.90M | 25.90M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 191.71M | 185.39M | 183.28M | 176.66M | 179.71M |
| Operating Income | 178.52M | 184.45M | 175.43M | 176.08M | 150.79M |
| Income Before Tax | 65.55M | -46.33M | 37.39M | 73.90M | 153.00M |
| Income Tax Expenses | 26.90M | 13.40M | 14.00M | 9.30M | 7.57M |
| Earnings from Continuing Operations | 38.65 | -59.72 | 23.39 | 64.59 | 145.42 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 38.65M | -59.72M | 23.39M | 64.59M | 145.42M |
| EBIT | 178.52M | 184.45M | 175.43M | 176.08M | 150.79M |
| EBITDA | 204.68M | 210.50M | 201.46M | 202.11M | 176.82M |
| EPS Basic | 0.61 | -0.95 | 0.37 | 1.01 | 2.25 |
| Normalized Basic EPS | 1.76 | 1.80 | 1.69 | 1.66 | 1.40 |
| EPS Diluted | 0.33 | -1.00 | 0.21 | 0.69 | 1.65 |
| Normalized Diluted EPS | 1.52 | 1.68 | 1.49 | 1.47 | 1.18 |
| Average Basic Shares Outstanding | 250.77M | 250.43M | 250.91M | 251.99M | 254.37M |
| Average Diluted Shares Outstanding | 294.31M | 272.39M | 294.21M | 295.00M | 318.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |